Company intelligence
Phastar
Bringing data to life
About Phastar
Phastar is an award-winning specialist biometrics and data science CRO, trusted by pharma, biotech, and medical device companies worldwide. With a global team of data specialists, it brings expertise, precision, and pace to every trial – because behind every data point is a patient waiting for treatment. Phastar doesn’t just deliver high-quality clinical trial data. It partners with clients to turn complexity into clarity. Leveraging technology, AI-enhanced analytics, advanced statistical methods, and deep therapeutic expertise, it accelerates regulatory approvals, ensures compliance with global standards and mitigates risk. Phastar has a proven track record in transforming complex data into clear, actionable intelligence, empowering its partners to accelerate drug development. With scalable, tailored solutions, it expedites trials – bringing life-changing therapies to patients faster.
Verified activity
Signals from Phastar
9 published signals
Presence & Recognition
Phastar is attending the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop in Rockville, MD, at Booth #13.
Reported by Phastar
Presence & Recognition
Phastar's Principal Data Scientist Evgeny Galimov will be presenting at CLAIR 2026 on how AI and self-service approaches can help bridge the gap between research questions and actionable evidence in clinical research.
Reported by Phastar
Research & Knowledge
Phastar published a case study detailing how the company designed a Bayesian Phase I/II trial for an emerging biotech preparing for its first-in-human oncology study to support dose escalation, early efficacy assessment, and regulatory acceptance from both the FDA and EMA.
Reported by Sam Caley
Partnerships
Phastar partnered with an emerging biotech to develop an innovative Bayesian Phase I/II oncology design for a first-in-human clinical trial.
Reported by Phastar
People
Phastar's Talent Acquisition Manager Nitu Kumari plays a key role in building and growing teams in India.
Reported by Phastar
Research & Knowledge
Phastar published a new case study on AI-powered drug repurposing in multiple sclerosis using real-world patient data to identify new indications for therapies.
Reported by Phastar
Presence & Recognition
Phastar is showcasing two contributions at the RSS International Conference 2026, including the Use of Estimands when Analysing Real-World Data presented by Andrew Elders and How Early Statistical Quality Oversight Can Reduce Avoidable Delays and Help Reliable Evidence Reach Patients Sooner authored by Shrutimita Pokhariyal.
Reported by Phastar
Presence & Recognition
Phastar hosted a webinar exploring regulatory expectations for Bayesian methods across the FDA, CDE, and EMA on 24 September 2026.
Reported by Phastar
Presence & Recognition
Phastar is attending the Medidata NEXT Shanghai event in Shanghai, Jing'an Shangri-La.
Reported by Phastar